Replies to post #518855 on Anavex Life Sciences Corp (AVXL)

[sab63090]

John,

Just wish she had used her COB title & influence to move much earlier in removing Missling; maybe with Terrie Kellmeyer in charge of the necessary future trials and as interim CEO , some of the people here will be able to see a much higher target than what I am currently expecting over the remaining months in 2026.

I want Missling to resign and I say screw his share holdings.....we don't need him nor his deceptions, secrecy, and self serving conniving.

[Steady_T]

Somehow the discussion has become AD or nothing.
Anavex has opportunities for Fragile X, Rett, PD, PDD, Schizophrenia.

Several of those will have trials that are shorter and smaller than AD. Anavex just needs one approval for any indication to prove the MOA and generate an income stream.
The question for me is what is the damage from Missling's firing and what is the plan going forward.
AD is just part of the picture.
We still don't know if the FDA will get an NDA for AD before the announced AD trial is completed or even started.

The share price is so low due to the uncertainty concerning Missling and the path forward. Assuming Missling wasn't cooking the books or fudging the data, once that is all made public the SP should climb some. How far depends on the damage and the chosen path forward.